EGFR and non-small cell lung carcinoma: The link between DTPs and apoptosis resistance was underscored by the finding that DTPs from EGFR-mutated NSCLC can survive gefitinib and osimertinib treatments by upregulating the anti-apoptotic protein MCL1 via the mTORC1-mediated post-transcriptional regulation of mRNA translation [42].